243 related articles for article (PubMed ID: 22425182)
1. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
Yang X; Di J; Zhang Y; Zhang S; Lu J; Liu J; Shi W
Biomed Pharmacother; 2012 Apr; 66(3):221-7. PubMed ID: 22425182
[TBL] [Abstract][Full Text] [Related]
2. Effect of fasudil on growth, adhesion, invasion, and migration of 95D lung carcinoma cells in vitro.
Yang X; Zhang Y; Wang S; Shi W
Can J Physiol Pharmacol; 2010 Sep; 88(9):874-9. PubMed ID: 20921973
[TBL] [Abstract][Full Text] [Related]
3. The Rho kinase inhibitor fasudil inhibits the migratory behaviour of 95-D lung carcinoma cells.
Yang X; Liu Y; Zong Z; Tian D
Biomed Pharmacother; 2010 Jan; 64(1):58-62. PubMed ID: 19879105
[TBL] [Abstract][Full Text] [Related]
4. Loss of RhoA expression prevents proliferation and metastasis of SPCA1 lung cancer cells in vitro.
Yang X; Zheng F; Zhang S; Lu J
Biomed Pharmacother; 2015 Feb; 69():361-6. PubMed ID: 25661383
[TBL] [Abstract][Full Text] [Related]
5. Intraradial administration of fasudil inhibits augmented Rho kinase activity to effectively dilate the spastic radial artery during coronary artery bypass grafting surgery.
Takagi T; Okamoto Y; Tomita S; Sato A; Yamaguchi S; Takuwa Y; Watanabe G
J Thorac Cardiovasc Surg; 2011 Aug; 142(2):e59-65. PubMed ID: 21397262
[TBL] [Abstract][Full Text] [Related]
6. [Suppression of hepatocellular carcinoma invasion and metastasis by Rho-kinase inhibitor Fasudil through inhibition of BTBD7-ROCK2 signaling pathway].
Hu K; Wang Z; Tao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Dec; 39(12):1221-7. PubMed ID: 25544168
[TBL] [Abstract][Full Text] [Related]
7. Fasudil inhibits proliferation and migration of Hep-2 laryngeal carcinoma cells.
Zhang X; Wu N
Drug Des Devel Ther; 2018; 12():373-381. PubMed ID: 29503530
[TBL] [Abstract][Full Text] [Related]
8. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549.
Zhu F; Zhang Z; Wu G; Li Z; Zhang R; Ren J; Nong L
Med Oncol; 2011 Jun; 28(2):565-71. PubMed ID: 20300976
[TBL] [Abstract][Full Text] [Related]
9. Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy.
Gao H; Hou F; Dong R; Wang Z; Zhao C; Tang W; Wu Y
Cardiovasc Ther; 2016 Oct; 34(5):352-9. PubMed ID: 27333569
[TBL] [Abstract][Full Text] [Related]
10. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
Deng L; Li G; Li R; Liu Q; He Q; Zhang J
Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
[TBL] [Abstract][Full Text] [Related]
11. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
Ying H; Biroc SL; Li WW; Alicke B; Xuan JA; Pagila R; Ohashi Y; Okada T; Kamata Y; Dinter H
Mol Cancer Ther; 2006 Sep; 5(9):2158-64. PubMed ID: 16985048
[TBL] [Abstract][Full Text] [Related]
12. LIMK1 depletion enhances fasudil-dependent inhibition of urethral fibroblast proliferation and migration.
Liang YC; Li XD; Wu YP; Ke ZB; Liu ZQ; Chen SH; Wei Y; Zheng QS; Xue XY; Xu N
J Cell Biochem; 2019 Aug; 120(8):12977-12988. PubMed ID: 30861189
[TBL] [Abstract][Full Text] [Related]
13. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
14. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 is an important factor for the metastasis and proliferation of human small cell lung cancer NCI-H446 cell.
Yeh D; Chen C; Sun MZ; Shao S; Hao L; Song Y; Gong L; Hu J; Wang Q
Anat Rec (Hoboken); 2009 Oct; 292(10):1584-92. PubMed ID: 19718715
[TBL] [Abstract][Full Text] [Related]
16. The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells.
Takeba Y; Matsumoto N; Watanabe M; Takenoshita-Nakaya S; Ohta Y; Kumai T; Takagi M; Koizumi S; Asakura T; Otsubo T
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1545-55. PubMed ID: 22481618
[TBL] [Abstract][Full Text] [Related]
17. Bufalin Inhibits NCI-H460 Human Lung Cancer Cell Metastasis In Vitro by Inhibiting MAPKs, MMPs, and NF-κB Pathways.
Wu SH; Hsiao YT; Kuo CL; Yu FS; Hsu SC; Wu PP; Chen JC; Hsia TC; Liu HC; Hsu WH; Chung JG
Am J Chin Med; 2015; 43(6):1247-64. PubMed ID: 26446205
[TBL] [Abstract][Full Text] [Related]
18. Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro.
Huang AC; Yang MD; Hsiao YT; Lin TS; Ma YS; Peng SF; Hsia TC; Cheng YD; Kuo CL; Chung JG
J Ethnopharmacol; 2016 Dec; 194():1043-1050. PubMed ID: 27833027
[TBL] [Abstract][Full Text] [Related]
19. [Apatinib Combined with CCI-779 Inhibits the Proliferation and Migration of Small Cell Lung Cancer NCI-H446 Cells In Vitro].
Liu C; Zhang H; Li Y; Zhang Z; Shi R; Xu S; Zhu G; Wang P; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2020 Apr; 23(4):216-222. PubMed ID: 32209188
[TBL] [Abstract][Full Text] [Related]
20. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
Chen XY; Dun JN; Miao QF; Zhang YJ
Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
